By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ImmunoGen, Inc. 

128 Sidney Street

Cambridge  Massachusetts  02139-4239  U.S.A.
Phone: 617-995-2500 Fax: 617-995-2510


SEARCH JOBS




Collaborations

GlaxoSmithKline (North Carolina) 

Raven Biotechnologies, Inc.  Partnership for the discovery and development of therapeutic MAbs for the treatment of ovarian cancer.

Medarex, Inc.  Partnership for the discovery and development of therapeutic MAbs for the treatment of ovarian cancer.





Company News
ImmunoGen (IMGN) Announces Departure Of Chief Development Officer 8/9/2016 11:15:38 AM
ImmunoGen (IMGN) Announces Webcasts Of Presentations At Upcoming Investor Conferences 8/5/2016 11:25:58 AM
ImmunoGen (IMGN) Reports Fourth Quarter And Fiscal Year 2016 Financial Results And Provides Quarterly Business Update 8/4/2016 12:08:03 PM
ImmunoGen (IMGN) Announces Conference Call To Discuss Its Fourth Quarter And Fiscal Year 2016 Financial Results 7/22/2016 7:40:06 AM
ImmunoGen (IMGN) Announces Pricing Of $100 Million Offering Of 4.50% Convertible Senior Notes Due 2021 6/15/2016 7:43:29 AM
ImmunoGen (IMGN) Announces Proposed $100 Million Offering Of Convertible Senior Notes Due 2021 6/14/2016 8:16:36 AM
ImmunoGen (IMGN) Reports Efficacy And Safety Data From A 46-Patient Cohort Of Mirvetuximab Soravtansine In Fra-Positive Ovarian Cancer 5/19/2016 12:11:45 PM
ImmunoGen (IMGN) Announces Webcasts Of Presentations At Upcoming Investor Conferences 5/11/2016 10:54:32 AM
10 Massachusetts Biotechs Devoting the Most Cash to R&D 5/5/2016 6:29:13 AM
ImmunoGen (IMGN) Reports Third Quarter Fiscal Year 2016 Financial Results And Provides Corporate Update 4/29/2016 10:33:47 AM
12345678910...
//-->